Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
Trial details
- Registry ID
- NCT07473843
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as ARO-ANG3
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of Zodasiran in Adolescent Participants With Homozygous Familial HypercholesterolemiaNCT07473843 | Arrowhead Pharmaceuticals | Phase 3 | Recruiting | 2028-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |